Infectious Disease Control

BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program

VANCOUVER, BC, Jan. 25, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to provide a corporate update on recent advancements of its vaccine platforms, and viral diagnostic and corporate objectives for 2021. BioVaxys is ple...

2021-01-25 21:00 402

Shanghai Electric Strengthens Environmental, Social, and Corporate Governance for Dubai MBR Solar Park Project

SHANGHAI, Jan. 21, 2021 /PRNewswire/ -- Shanghai Electric Group ("Shanghai Electric" or "the Company") has strengthened its environmental, social, and corporate governance for the Phase 5 project forDubai's 900MW Mohammed bin Rashid Al Maktoum Solar Park (MBR Solar Park), winning praise from Shua...

2021-01-21 16:13 4099

LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Japan and Brazil; Italy Recommends Expansion of Microfluidic Antigen Testing

LONDON, Jan. 21, 2021 /PRNewswire/ -- LumiraDx, the next-generation point-of-care diagnostic testing company, announced today multinational approvals of its SARS-CoV-2 Antigen Test. With approvals inJapan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test is now available to patie...

2021-01-21 16:00 870

Seegene to advance business in Latin America in the New Year

SEOUL, South Korea, Jan. 21, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) said Wednesday that it is expanding its business inLatin America in the new year with a strong focus on its multiplex assay product. Seegene said it received an approval f...

2021-01-21 07:56 677

ERBA Mannheim Launches 2nd Generation SARS-CoV-2 RT-PCR Assay with room temperature storage

LONDON, Jan. 21, 2021 /PRNewswire/ -- In response to the ongoing COVID-19 pandemic, Erba today launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2. To overcome challenges in older COVID-19 molecular tests, Erba's Cambridge (UK)-based development team has carefully engineered a ...

2021-01-21 06:00 1064

InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization

BOULDER, Colorado, Jan. 19, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Measles and Rubella (MR) antigen qu...

2021-01-19 16:00 615

Air France Awarded 4-Star "COVID-19 Airline Safety Rating" By Skytrax

PARIS, Jan. 15, 2021 /PRNewswire/ -- Air France has been certified with the  COVID-19 Airline Safety Rating following the global audit conducted by the international air transport rating agency Skytrax. This audit, carried out in December 2020 on several Air France medium and long-haul flights, eva...

2021-01-15 12:24 1174

Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization

- Ortho's VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA). - With utility for mass-scale testing and same-day results for labs, Ortho's latest COVID-19 solution can run up to 130 tests ...

2021-01-13 03:13 743

Guide Sensmart Launches New Guide QT Series IR Fever Warning System for Temperature Measurement featuring 5-minute Easy Installation

WUHAN, China, Jan. 13, 2021 /PRNewswire/ -- On December 28, 2020, China's leading company in epidemic prevention and temperature measurement, launched a new fever screening product: the Guide QT Series IR Fever Warning System with infrared thermal imaging and an automatic temperature measuremen...

2021-01-13 01:47 4355

PT Mowilex to Screen Its Workers with COVID-19 Tests from Abbott

JAKARTA, Indonesia, Jan. 12, 2021 /PRNewswire/ -- Indonesian paint manufacturer PT Mowilex is safeguarding workers' health by purchasing COVID-19 diagnostic tests from U.S. health care company Abbott. PT Mowilex will roll out an aggressive testing program to enhance distancing and hygiene protoco...

2021-01-12 14:43 848

Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients

SUZHOU, China, Jan. 10, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients. The investigator initiated trial conducted by Dr.Andy Goren and Dr. Flávio Adsuara C...

2021-01-10 16:55 1461

Medical Waste Management Inherits a Multi-billion Dollar Opportunity from the Ongoing Pandemic

Asia-Pacific presents immense growth opportunities for medical waste management market participants as regulations mature and are thoroughly enforced, says Frost & Sullivan SANTA CLARA, Calif., Jan. 7, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Growth Opportunities in the Medical Wa...

2021-01-07 21:10 1222

INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18

- DNA immunotherapy candidate VGX-3100 demonstrated clinically significant reduction of HPV-16/18-associated precancerous vulvar lesions in 63% of treated participants six months after treatment - Phase 2 results indicate that VGX-3100 can be a safe, tolerable and efficacious adjunct to current ...

2021-01-06 21:00 1907

INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vaccine Candidate, INO-4800, in Greater China

PLYMOUTH MEETING, Pa. and SUZHOU, China, Jan. 4, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("A...

2021-01-04 21:00 2578

RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib

Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material safety differences between opaganib and control arms Consistent trends demonstrate greater improvement in reducing oxygen requirement by end of ...

2020-12-31 22:38 6097

INEX Innovate's CORO(TM) Real-Time RT-PCR SARS-CoV-2 Kit for the detection of COVID-19 obtains Singapore's Health Sciences Authority Provisional Authorisation

* The COVID-19 pandemic has seen in excess of 81 million confirmed cases globally and more than 1.7 million deaths and rising daily (1) * CORO™ Real-Time RT-PCR SARS-CoV-2 for the diagnosis of COVID-19, was developed based on three genes recommended by the World Health Organisation (WHO) * ...

2020-12-29 17:24 1232

Universiti Teknologi Malaysia Community responded to COVID-19 threats through R&D

JOHOR BAHRU, Malaysia, Dec. 29, 2020 /PRNewswire/ -- Researchers from Universiti Teknologi Malaysia (UTM) have swung into action to respond to the threat posed by COVID-19 pandemic. Frugal innovations and inventions were developed to improve efficiency and quality in creating relevant and adaptab...

2020-12-29 10:00 1136

Thailand continues to reopen for travellers slowly and safely

BANGKOK, Dec. 23, 2020 /PRNewswire/ -- Thailand's tourism sector continues to safely and slowly reopen welcoming international travellers to the country with special tourist initiatives, while also remaining vigilant by enforcing strict public health guidelines to protect all during the ongoing C...

2020-12-23 15:53 1548

Irish Technology deployed in South Africa as part of International Music Events re-opening

DUBLIN, Dec. 23, 2020 /PRNewswire/ -- Irish-based Health Passport Europe has partnered with Big Concerts and The Entertainment Group to safely re-open the events industry inSouth Africa, using latest developments in rapid COVID-19 testing and the secure Health Passport Europe mobile technology. ...

2020-12-23 03:15 2049

RedHill's Phase 2/3 COVID-19 Study of Opaganib Passes Second DSMB with Unanimous Recommendation to Continue

Independent DSMB unanimously recommends continuation of the global Phase 2/3 study of orally-administered opaganib in severe COVID-19 based on review of unblinded safety data from 155 treated patients Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021 Top-line d...

2020-12-22 20:38 3042
12345 ... 39